JSMC
LABU icon

Jess S. Morgan & Co’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Jess S. Morgan & Co’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$200K Sell
1,425
-58
-4% -$10.6K 0.17% 36
2022
Q2 		$200K Buy
+1,483
New +$253K 0.21% 36

Other funds holding LABU

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Jess S. Morgan & Co's LABU Position: Q3 2022 in Review

Jess S. Morgan & Co reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 3.9% in Q3 2022, selling an estimated $10.6K and leaving 1,425 shares worth $200K. The position accounts for 0.17% of the portfolio, ranked #36.

Jess S. Morgan & Co first reported a position in LABU in Q2 2022 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • Jess S. Morgan & Co held 1,425 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $200K as of Q3 2022.
  • Jess S. Morgan & Co sold 58 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $10.6K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.17% of Jess S. Morgan & Co's portfolio in Q3 2022, its #36 holding.
  • Jess S. Morgan & Co first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on Jess S. Morgan & Co's 13F filing for Q3 2022, filed 21 Oct 2022.